CME / MOC

The following ASH Academy offerings have been developed by subject-matter experts to meet your continuing medical education (CME) and maintenance of certification (MOC) needs. These clinically-relevant educational resources in hematology support your continuous professional development by offering various types of credit.

out of 7 CME/MOC products listed

Credit Types

ASH Self-Assessment Program (ASH-SAP)

Hematologists and others working in hematology-related fields need to stay current with the latest advances in the rapidly evolving disciplines of adult and pediatric hematology including benign and malignant disorders. The American Society of Hematology Self-Assessment Program (ASH-SAP), Sixth Edition, is the only complete, comprehensive, educational resource available that fulfills this need.

  • 23 pertinent chapters-7 with multimedia featuring 3D animation and audio
  • Question & Answer Book with 285 multiple-choice questions
  • Earn up 70 CME/MOC Credits with 6 tests through the ASH Academy. Tests may be taken individually or all of them at one time

ASH-SAP, 6th edition

CME
MOC

Six tests combined for 70 points:

Lab Hematology & Cellular Therapy: 15 points
Consultative Hematology: 5 points
Anemia, Iron Physiology and Disorder: 10 points
Thrombosis & Hemostasis: 10 points
Myeloid Diseases: 15 points
Lymphoid Disorders: 15 points

Digital 

  • Online version of textbook.
  • Online access to six separate tests which combine to offer 70 continuing medical education (CME) and American Board of Internal Medicine (ABIM) Maintenance of Certification points.

Premier 

  • Print textbook and Q&A book
  • Online version of textbook.
  • Online access to six separate tests which combine to offer 70 continuing medical education (CME) and American Board of Internal Medicine (ABIM) Maintenance of Certification points.

logo   badge


Credits available from the 6 tests include:

  • 70 AMA PRA Category 1 Credits™
  • 70 ABIM Medical Knowledge Points
  • 70 American Board of Pathology SAM Credits


Purchase Options Resident/Graduate
Medical Student Member
US/International
Associate Member
Members Non-Members
Digital $150.00 $250.00 $380.00 $520.00
Premier $250.00 $360.00 $490.00 $630.00




Biosimilars Program

A New Era of Hematology/Oncology Management Considerations

This two-part, audio-guided online course presents practical, foundational information on biosimilars, while also addressing issues and barriers most commonly encountered in the clinical setting.


Biosimilars Program

CME
MOC
Part I: What Do You Know?
Experts define and present key didactic information to provide practical, foundational information on biosimilars
Part II: What Would You Do?
Learners interpret the foundational information about biosimilars through the evaluation of three case-based scenarios

Faculty:

Jeffrey Crawford, MD
Duke Cancer Center
Durham, NC

Gary H. Lyman, MD
Fred Hutchinson Cancer Research Center, University of Washington
Seattle, WA

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

CML Program

CML Interactive Cases: An Immersive Simulated Learning Experience

This educational activity will provide an opportunity to explore two different CML cases. Learners will navigate treatment decisions based on patient presentation, history, and other findings that may impact the therapeutic approach.


CML Program

CME
MOC
Case 1
This case explores risk assessment and initial treatment approach, monitoring treatment response, managing side effects, long-term therapy, and the potential for treatment-free remission.
Case 2
This case explores possible reasons for treatment failure, monitoring and optimizing treatment adherence, monitoring treatment response and side effects, and multiple lines of therapy based on treatment history and risk.

Faculty:

Jessica Altman, MD
Northwestern University
Chicago, IL

Elizabeth Hexner, MD, MS
University of Pennsylvania
Philadelphia, PA

Jorge Cortes, MD
MD Anderson Cancer Center
Houston, TX

Kendra Sweet, MD
Moffitt Cancer Center
Tampa, FL


MDS+AML MATTER Program

The goals of this set of simulated patient cases are to provide guidance to the interdisciplinary team caring for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) on:

  • The optimal diagnosis and classification of both MDS and AML
  • Risk stratification and individualized treatment selection
  • Assessment of treatment responses
  • Monitoring for and mitigation of adverse events, and
  • Patient education regarding prognosis and treatment choices

These activities are supported by an independent medical education grant from Celgene.


MDS+AML MATTER Program

CME
MOC
Faculty:

Robert Paul Hasserjian, MD
Massachusetts General Hospital
Harvard Medical School
Boston, MA

Kirsten Roblee, BSN, RN, OCN
The James Cancer Hospital and Solove Research Institute
Columbus, OH

B. Douglas Smith, MD
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Baltimore, MD
back to top